206 participants
BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-24
- Start Date:
- 2024-08-07
- Completion:
- 2026-08-07
Conditions
- Lymphoblastic Lymphoma, Adult
- Lymphoblastic Leukemia, Acute T-cell
Interventions
- DRUG
- OTHER
No Results Yet